Shares of Colgate-Palmolive (NYSE:CL) have been given a consensus recommendation of “Hold” by the eighteen research firms that are covering the stock, Marketbeat reports. Five equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $74.27.

A number of research firms have recently weighed in on CL. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Monday. Morgan Stanley reduced their target price on shares of Colgate-Palmolive from $69.00 to $67.00 and set an “equal weight” rating for the company in a research report on Thursday, June 21st. Argus raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Friday, May 25th. They noted that the move was a valuation call. Sanford C. Bernstein reissued a “market perform” rating and set a $72.00 target price on shares of Colgate-Palmolive in a research report on Thursday, May 24th. Finally, ValuEngine downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Wednesday, May 2nd.

In other Colgate-Palmolive news, insider Daniel B. Marsili sold 19,500 shares of the stock in a transaction that occurred on Tuesday, May 15th. The shares were sold at an average price of $61.69, for a total value of $1,202,955.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Vice Chairman Franck J. Moison sold 80,000 shares of the stock in a transaction that occurred on Tuesday, May 15th. The stock was sold at an average price of $61.75, for a total transaction of $4,940,000.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 161,579 shares of company stock valued at $10,215,058. 1.02% of the stock is owned by insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of CL. Old Mutual Global Investors UK Ltd. lifted its stake in Colgate-Palmolive by 636.9% in the 1st quarter. Old Mutual Global Investors UK Ltd. now owns 3,463,287 shares of the company’s stock worth $248,248,000 after purchasing an additional 2,993,298 shares in the last quarter. First Eagle Investment Management LLC lifted its stake in Colgate-Palmolive by 45.7% in the 1st quarter. First Eagle Investment Management LLC now owns 7,830,595 shares of the company’s stock worth $561,297,000 after purchasing an additional 2,455,839 shares in the last quarter. BlackRock Inc. lifted its stake in Colgate-Palmolive by 3.0% in the 1st quarter. BlackRock Inc. now owns 53,953,299 shares of the company’s stock worth $3,867,373,000 after purchasing an additional 1,592,608 shares in the last quarter. Findlay Park Partners LLP purchased a new stake in Colgate-Palmolive in the 1st quarter worth approximately $107,520,000. Finally, Loomis Sayles & Co. L P lifted its stake in Colgate-Palmolive by 211.9% in the 1st quarter. Loomis Sayles & Co. L P now owns 1,782,313 shares of the company’s stock worth $127,756,000 after purchasing an additional 1,210,891 shares in the last quarter. Institutional investors and hedge funds own 73.17% of the company’s stock.

Shares of Colgate-Palmolive stock traded down $0.18 on Friday, reaching $65.78. 3,310,700 shares of the company traded hands, compared to its average volume of 4,302,249. Colgate-Palmolive has a 52 week low of $61.28 and a 52 week high of $77.91. The company has a market capitalization of $56.41 billion, a P/E ratio of 22.92, a P/E/G ratio of 2.63 and a beta of 0.75. The company has a quick ratio of 0.75, a current ratio of 1.08 and a debt-to-equity ratio of 64.85.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, April 27th. The company reported $0.74 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a net margin of 13.30% and a return on equity of 1,486.69%. The firm had revenue of $4 billion during the quarter, compared to the consensus estimate of $4.01 billion. During the same period in the prior year, the firm earned $0.67 EPS. The company’s revenue was up 6.4% compared to the same quarter last year. equities analysts expect that Colgate-Palmolive will post 3.13 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 15th. Investors of record on Wednesday, July 18th will be issued a $0.42 dividend. This represents a $1.68 annualized dividend and a yield of 2.55%. The ex-dividend date of this dividend is Tuesday, July 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.54%.

Colgate-Palmolive declared that its board has approved a stock buyback program on Monday, June 18th that allows the company to repurchase $5.00 billion in shares. This repurchase authorization allows the company to purchase up to 9% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s management believes its shares are undervalued.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.